Related Experiment Video

Updated: Aug 11, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

The future of new pure antiestrogens in clinical breast cancer

A E Wakeling1

  • 1Bioscience I, ICI Pharmaceuticals, Macclesfield, Cheshire, United Kingdom.

Breast Cancer Research and Treatment
|January 1, 1993
PubMed

Insights

New pure antiestrogens, unlike tamoxifen, lack estrogenic activity. These compounds show promise for more effective breast cancer treatment, potentially leading to better tumor remission.

Area of Science:

  • Endocrinology
  • Medical Oncology
  • Pharmacology

Background:

  • Existing antiestrogens like tamoxifen exhibit partial agonist (estrogenic) activity.
  • This estrogenic activity limits their effectiveness in blocking estrogen's mitogenic action on breast tumors.

Purpose of the Study:

  • To identify and characterize pure antiestrogens with no partial agonist activity.
  • To evaluate the therapeutic potential of pure antiestrogens in breast cancer treatment.

Main Methods:

  • Discovery and characterization of pure antiestrogens ICI 164,384 and ICI 182,780.
  • Comparative analysis of pure antiestrogens against tamoxifen.
  • Assessment of experimental data predicting clinical efficacy.

Main Results:

  • Pure antiestrogens ICI 164,384 and ICI 182,780 were discovered and characterized.
  • These compounds are predicted to be more effective than tamoxifen in breast cancer treatment.
  • Potential for improved efficacy in patients with tamoxifen-resistant or first-line advanced breast cancer.

Conclusions:

  • Pure antiestrogens represent a significant advancement over existing therapies like tamoxifen.
  • They offer the potential for more rapid, complete, and durable tumor remissions in breast cancer patients.
  • Further clinical trials with ICI 182,780 are warranted to confirm these predictions.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...